ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Jamaica Dogwood Extract

Also known as: Jamaica Dogwood, Jamaican Dogwood, Fishfuddle, Piscidia, Piscidia piscipula

Overview

Jamaica Dogwood extract is primarily derived from the root bark of the *Piscidia piscipula* tree, native to Central America and the Caribbean. Historically, it has been used in traditional medicine for its sedative, analgesic, and antispasmodic properties, and also as a fish poison. Its primary applications in traditional contexts include addressing insomnia, anxiety, and muscle spasms. Key characteristics observed in preclinical studies include sedative, anxiolytic (anxiety-reducing), and antispasmodic effects. However, it is crucial to note that the research maturity for Jamaica Dogwood is low; there are no published human clinical trials meeting rigorous scientific standards. The existing evidence is predominantly based on animal studies and historical traditional use, with a significant lack of high-quality randomized controlled trials (RCTs) or systematic reviews in humans. This limits the understanding of its efficacy and safety in human populations.

Benefits

The primary benefits of Jamaica Dogwood, as observed in animal studies, include sedative, anxiolytic, and antispasmodic effects. These properties are attributed to its isoflavone constituents. For instance, mouse models have demonstrated significant anxiolytic and sedative activity. Secondary effects, such as pain relief and muscle spasm reduction, have also been noted in animal studies and traditional medicine, but these have not been confirmed in controlled human trials. There is no clinical data to support specific benefits for particular human populations, and its use is generally contraindicated in vulnerable groups such as children, pregnant or breastfeeding women, and the elderly due to potential toxicity. The effect sizes and clinical significance of Jamaica Dogwood have not been established in humans due to the absence of human RCTs, and its time course of action in humans remains unknown, though animal studies suggest acute effects.

How it works

Jamaica Dogwood's purported sedative and antispasmodic effects are believed to be mediated through central nervous system depressant activity and smooth muscle relaxation. These actions are thought to be primarily due to its isoflavone constituents. Animal studies have indicated a depressant action on uterine smooth muscle and anxiolytic effects in mice. However, the specific molecular targets and detailed biological pathways involved remain largely unidentified. Furthermore, the bioavailability and pharmacokinetics of Jamaica Dogwood in humans have not been documented, meaning how it is absorbed, distributed, metabolized, and excreted in the human body is not understood.

Side effects

The overall safety profile of Jamaica Dogwood in humans is largely unknown due to the complete absence of clinical trials. While animal studies suggest low toxicity at very high doses (e.g., up to 90 g/kg orally in rats with no observed toxic effects), these findings cannot be directly extrapolated to humans. Common side effects in humans are not documented, but reported symptoms of overdose include numbness, tremors, excessive salivation, and sweating. Jamaica Dogwood is considered potentially toxic to fish and, by extension, potentially to humans. Therefore, its use is cautioned or contraindicated in vulnerable populations, including children, pregnant or breastfeeding women, and the elderly. Drug interactions are not well-studied, but caution is strongly advised, particularly with other central nervous system depressants, due to its potential CNS depressant effects. Contraindications include pregnancy, breastfeeding, use in children, use in the elderly, and any unsupervised administration.

Dosage

There is no established minimum effective dose or optimal dosing regimen for Jamaica Dogwood in humans due to the complete lack of clinical data. Traditional use has involved teas, tinctures, and extracts derived from the root bark, but the chemical composition and potency of these preparations can vary significantly depending on the geographic source of the plant. The maximum safe dose for humans is unknown, and extreme caution is advised due to its potential toxicity. Information regarding the optimal timing of administration and factors affecting its absorption in humans is also not available, further underscoring the need for caution and the absence of clear usage guidelines.

FAQs

Is Jamaica Dogwood safe for self-administration?

No, self-administration of Jamaica Dogwood is not recommended without medical supervision due to its potential toxicity and the complete lack of human safety data. Professional guidance is essential.

Does it effectively treat insomnia or pain in humans?

There is no clinical evidence from human trials to support the efficacy of Jamaica Dogwood for treating insomnia or pain. Any perceived benefits are inferred from animal studies and traditional use, not confirmed human data.

Can it be used in children or pregnant women?

No, Jamaica Dogwood is contraindicated for use in children and pregnant or breastfeeding women due to significant safety concerns and the absence of any safety data for these vulnerable populations.

How soon do effects appear?

The onset of effects in humans is unknown. Animal studies suggest a rapid onset of sedative effects, but this cannot be reliably applied to human physiology.

Research Sources

  • https://www.herbalreality.com/herb/jamaican-dogwood/ – This systematic review of animal studies indicates that Jamaica Dogwood exhibits sedative, anxiolytic, and antispasmodic effects in preclinical models. However, it explicitly states that no human clinical trials were found, highlighting the limitation of evidence to animal models and the lack of clinical applicability.
  • https://sbrmc.adam.com/content.aspx?productid=107&pid=33&gid=000258 – This narrative review summarizes the traditional uses of Jamaica Dogwood root bark for sedation, analgesia, and antispasmodic purposes. It emphasizes the potential toxicity and critically notes the absence of human clinical trials, underscoring that safety concerns warrant extreme caution in its use.
  • https://jcsm.aasm.org/doi/pdf/10.5664/jcsm.26314 – This review article, which includes Jamaica Dogwood among other herbal sedatives, acknowledges its sedative effects observed in animal studies. However, it explicitly states the lack of human efficacy data and highlights incomplete adverse event data, indicating low evidence for its use and better evidence for other agents.

Supplements Containing Jamaica Dogwood Extract

Cramp Care by Herb Pharm
65

Cramp Care

Herb Pharm

Score: 65/100